Healthcare Industry News: S.A.
News Release - March 19, 2009
Oragenics, Inc. Announces Management Changes
ALACHUA, Fla.--(HSMN NewsFeed)--Oragenics, Inc. (OTCBB:ORNI ) (NYSE Alternext PariS.A.ONI) today announced that S.A.ley B. Stein resigned as President, Chief Executive Officer and director of Oragenics, Inc.(the "Company"), effective yesterday and will thereafter continue to provide services to the Company aS.A. advisor. Mr. Stein’s resignation is not due to any disagreement with the Company on any matter related to its operations, policies, and practices.David Hirsch, the Company’s Chief Financial Officer and Chief Operating Officer, will assume additional responsibilitieS.A. acting Chief Executive Officer and Dr. Robert T. Zahradnik, PhD., the Company’s Vice President of Business Development, will assume the role of acting Chief Operating Officer formerly served by Mr. Hirsch.
Richard T. Welch, Chairman of the Board, commented "We look forward to continuing to work with S.A. in certain select matters relating to strategic alternatives, business development and capital strategies. Also, the Board is very confident that David Hirsch has the requisite skill sets to effectively lead the Company at this time and continue to move things forward in a very exciting year for the Company".
About Oragenics, Inc.
Oragenics, Inc., iS.A.biopharmaceutical company engaged in developing unique proprietary technologies, some of which are being commercialized and sold in the over-the-counter consumer healthcare market. The company also haS.A.number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diS.A.es, diagnostics, and oral health. The company is located in Alachua, Florida, U.S.A., approximately 15 miles from the campus of the University of Florida in Gainesville.
Safe Harbor S.A.ement: Under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking S.A.ements that reflect the Company’s current views with respect to future eventS.A.d financial performance. These forward-looking S.A.ementS.A.e based on management’s beliefS.A.d assumptionS.A.d information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking S.A.ements. Investors should be cautious in relying on forward-looking S.A.ements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking S.A.ements. These factors include, but are not limited to those set forth in our most recently filed annual report on Form 10-KSB and quarterly report on Form 10-Q, and other factors detailed from time to time in filings with the U.S. SecuritieS.A.d Exchange Commission. We expressly disclaim any responsibility to update forward-looking S.A.ements.
Source: Oragenics
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!